Tag: CBT > medical cannabis research

Industry Headlines

Tilray Medical Publishes Pioneering Research on Pharmacokinetics of THC, CBD Formulations

The new study provides insight into the bioavailability of medical cannabis formulations for therapeutic treatment.

June 26, 2025

Columns

Innovating for the Benefit of Patients in Medical Cannabis (Opinion)

Poor bioavailability formulations in orally delivered medical cannabis have left an innovation gap for patients.

April 28, 2025

Legislation and Regulation

DOJ Will No Longer Defend Administrative Law Judges From Removal

The announcement could bolster MMJ International Holdings’ ongoing lawsuit against the DEA over a medical cannabis research application.

February 25, 2025

Cannabis Industry Research

The Man Behind DEA’s Federal Marijuana Scam

DEA Senior Policy Adviser Matthew Strait defied presidential mandates for medical research, MMJ International Holdings claims.

January 28, 2025

Industry Headlines

Does Medical Cannabis Have Physical, Mental Health Risks? Rutgers Health Kicks Off Study

Rutgers Health researchers will emphasize cannabis use disorder, which involves tolerance and dependence, in the five-year, federally funded study.

December 17, 2024

Industry Headlines

DEA Continues to Block MMJ Marijuana Drug Development for Neurological Disorder

MMJ submitted an FDA Investigational New Drug application for a cannabis-derived medication.

December 11, 2024

Industry Headlines

FDA Clears MAPS Researchers to Proceed With Cannabis Study for Veterans With PTSD

The Multidisciplinary Association for Psychedelic Studies (MAPS) researchers negotiated with the FDA for three years.

November 22, 2024

Cannabis Industry Research

Medical Marijuana Act Signed by Biden Would Hinder Research Under Rescheduling

The Medical Marijuana and Cannabidiol Research Expansion Act’s requirements would remain under Schedule III, a congressional researcher says.

September 20, 2024

International

Tilray Medical Launches Redecan Cannabis Brand in Australia

The company’s EU-GMP-certified medical cannabis products are now available in Australia with a prescription.

September 18, 2024

Industry Headlines

MMJ BioPharma Suing DEA Over Cannabis Reform, Medical Research

The biopharmaceutical company filed a lawsuit, citing ‘unjustified’ delays in processing an application for medical research.

September 11, 2024

Cannabis Industry Research

Raphael Pharmaceutical Issues Letter to Shareholders

The letter highlights the company’s exclusive relationship with Rambam Health Care Campus, differentiated cannabinoid-based technology platform, promising lead product candidate for rheumatoid arthritis, recently commenced clinical study, broader pipeline opportunities, and overall mission and vision.

July 9, 2024

Industry Headlines

AYR Wellness and Lake Erie College of Osteopathic Medicine Partner on Medical Research Studying ‘Quality of Life’ Benefits of Medical Cannabis

The organizations published the results of the first of five studies and co-hosted a Pennsylvania Medical Marijuana Program Research Summit.

April 30, 2024